Long-term persistence of anti-HBs after hepatitis B vaccination among adults: 8-year results
The long-term persistence of hepatitis B surface antibody (anti-HBs) after hepatitis B vaccination among adults was not known clearly. This study aimed to assess the immunogenicity and persistence of antibodies 8 years after hepatitis B immunization with different vaccination schedules among adults...
Main Authors: | Wen Ren, Jingjing Ren, Zikang Wu, Lingzhi Shen, Huan Shan, Xuewei Dai, Jing Li, Ying Liu, Yan Qiu, Jun Yao, Lanjuan Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-03-01
|
Series: | Human Vaccines & Immunotherapeutics |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/21645515.2019.1666612 |
Similar Items
-
Modeling long-term persistence after 8 years of hepatitis B booster vaccination in 5- to 15-year-old children
by: Yan Qiu, et al.
Published: (2022-11-01) -
Long-term persistence of anti-HBs after hepatitis B vaccination among isolated anti-HBc positive adults in China: 8-years results
by: Wen Ren, et al.
Published: (2021-04-01) -
The effect of hepatitis B vaccination after five years on an entire population in an insular region of Southeast China
by: Ying Liu, et al.
Published: (2021-05-01) -
The Safety, Immunogenicity, and Immunopersistence of Hepatitis A Vaccine in HBs-Ag-Positive Participants: A Retrospective Study
by: Xiaodan Wang, et al.
Published: (2021-06-01) -
The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
by: Caroline Van Den Ende, et al.
Published: (2017-08-01)